Status:
WITHDRAWN
Redefining Survivorship: POWER to Maximize Physical Function for Survivors of Critical Illness
Lead Sponsor:
Kirby Mayer
Collaborating Sponsors:
Nathan Johnson, PT, PhD
Ashley Montgomery-Yates, MD
Conditions:
Critical Illness
Muscle Atrophy or Weakness
Eligibility:
All Genders
18-99 years
Phase:
PHASE1
PHASE2
Brief Summary
Patients surviving critical illness experience significant skeletal muscle dysfunction and weakness. Muscle atrophy suffered during critical illness has a long-term impact on the functionality and mob...
Eligibility Criteria
Inclusion
- admitted to medicine ICU
- acute respiratory failure or ARDS
- sepsis
- anticipated \>48 hours MV
Exclusion
- acute neurologic infarct
- non-ambulatory prior to hospitalization
- pregnant
Key Trial Info
Start Date :
December 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04058977
Start Date
December 1 2021
End Date
September 1 2024
Last Update
October 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kentucky
Lexington, Kentucky, United States, 40536